BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 26527623)

  • 21. Knockdown of HMGA1 inhibits human breast cancer cell growth and metastasis in immunodeficient mice.
    Di Cello F; Shin J; Harbom K; Brayton C
    Biochem Biophys Res Commun; 2013 Apr; 434(1):70-4. PubMed ID: 23545254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HMGA1 Overexpression is Associated With the Malignant Status and Progression of Breast Cancer.
    Qi C; Cao J; Li M; Liang C; He Y; Li Y; Li J; Zheng X; Wang L; Wei B
    Anat Rec (Hoboken); 2018 Jun; 301(6):1061-1067. PubMed ID: 29316384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fra-1 Regulates the Expression of HMGA1, Which is Associated with a Poor Prognosis in Human Esophageal Squamous Cell Carcinoma.
    Toyozumi T; Hoshino I; Takahashi M; Usui A; Akutsu Y; Hanari N; Murakami K; Kano M; Akanuma N; Suitoh H; Matsumoto Y; Sekino N; Komatsu A; Matsubara H
    Ann Surg Oncol; 2017 Oct; 24(11):3446-3455. PubMed ID: 27882471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HMGA1 Regulates the Expression of Replication-Dependent Histone Genes and Cell-Cycle in Breast Cancer Cells.
    Petrosino S; Pacor S; Pegoraro S; Gazziero VA; Canarutto G; Piazza S; Manfioletti G; Sgarra R
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HMGA1 protein over-expression is a frequent feature of epithelial ovarian carcinomas.
    Masciullo V; Baldassarre G; Pentimalli F; Berlingieri MT; Boccia A; Chiappetta G; Palazzo J; Manfioletti G; Giancotti V; Viglietto G; Scambia G; Fusco A
    Carcinogenesis; 2003 Jul; 24(7):1191-8. PubMed ID: 12807722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative proteomic analysis identifies new effectors of FOXM1 involved in breast cancer cell migration.
    Ye X; Zhang Y; He B; Meng Y; Li Y; Gao Y
    Int J Clin Exp Pathol; 2015; 8(12):15836-44. PubMed ID: 26884854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2.
    Kalashnikova EV; Revenko AS; Gemo AT; Andrews NP; Tepper CG; Zou JX; Cardiff RD; Borowsky AD; Chen HW
    Cancer Res; 2010 Nov; 70(22):9402-12. PubMed ID: 20864510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High mobility group protein HMGA1 expression in breast cancer reveals a positive correlation with tumour grade.
    Flohr AM; Rogalla P; Bonk U; Puettmann B; Buerger H; Gohla G; Packeisen J; Wosniok W; Loeschke S; Bullerdiek J
    Histol Histopathol; 2003 Oct; 18(4):999-1004. PubMed ID: 12973668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo posttranslational modifications of the high mobility group A1a proteins in breast cancer cells of differing metastatic potential.
    Edberg DD; Bruce JE; Siems WF; Reeves R
    Biochemistry; 2004 Sep; 43(36):11500-15. PubMed ID: 15350136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Implications of Extracellular HMGA1 in Breast Cancer.
    Méndez O; Pérez J; Soberino J; Racca F; Cortés J; Villanueva J
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31779212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of high mobility group A1 protein in human uveal melanomas: implication for prognosis.
    Qu Y; Wang Y; Ma J; Zhang Y; Meng N; Li H; Wang Y; Wei W
    PLoS One; 2013; 8(7):e68724. PubMed ID: 23935884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated expression of HMGA1 correlates with the malignant status and prognosis of non-small cell lung cancer.
    Zhang Z; Wang Q; Chen F; Liu J
    Tumour Biol; 2015 Feb; 36(2):1213-9. PubMed ID: 25344216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HMGA1 Has Predictive Value in Response to Chemotherapy in Gastric Cancer.
    Pádua D; Pinto DF; Figueira P; Pereira CF; Almeida R; Mesquita P
    Curr Oncol; 2021 Dec; 29(1):56-67. PubMed ID: 35049679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HMGA1 Promotes Hepatic Metastasis of Colorectal Cancer by Inducing Expression of Glucose Transporter 3 (GLUT3).
    Yang M; Guo Y; Liu X; Liu N
    Med Sci Monit; 2020 Sep; 26():e924975. PubMed ID: 32989212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AP-1 Signaling by Fra-1 Directly Regulates HMGA1 Oncogene Transcription in Triple-Negative Breast Cancers.
    Tolza C; Bejjani F; Evanno E; Mahfoud S; Moquet-Torcy G; Gostan T; Maqbool MA; Kirsh O; Piechaczyk M; Jariel-Encontre I
    Mol Cancer Res; 2019 Oct; 17(10):1999-2014. PubMed ID: 31300541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HMGA1 silencing restores normal stem cell characteristics in colon cancer stem cells by increasing p53 levels.
    Puca F; Colamaio M; Federico A; Gemei M; Tosti N; Bastos AU; Del Vecchio L; Pece S; Battista S; Fusco A
    Oncotarget; 2014 May; 5(10):3234-45. PubMed ID: 24833610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting HMGA1 contributes to immunotherapy in aggressive breast cancer while suppressing EMT.
    Chang X; Liu J; Yang Q; Gao Y; Ding X; Zhao J; Li Y; Liu Z; Li Z; Wu Y; Zuo D
    Biochem Pharmacol; 2023 Jun; 212():115582. PubMed ID: 37146833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mass spectrometric analysis of high-mobility group proteins and their post-translational modifications in normal and cancerous human breast tissues.
    Zou Y; Wang Y
    J Proteome Res; 2007 Jun; 6(6):2304-14. PubMed ID: 17455969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hmga1 is differentially expressed and mediates silencing of the CD4/CD8 loci in T cell lineages and leukemic cells.
    Xi Y; Watanabe S; Hino Y; Sakamoto C; Nakatsu Y; Okada S; Nakao M
    Cancer Sci; 2012 Mar; 103(3):439-47. PubMed ID: 22106824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of the focal adhesion protein kindlin-1 in breast cancer growth and lung metastasis.
    Sin S; Bonin F; Petit V; Meseure D; Lallemand F; Bièche I; Bellahcène A; Castronovo V; de Wever O; Gespach C; Lidereau R; Driouch K
    J Natl Cancer Inst; 2011 Sep; 103(17):1323-37. PubMed ID: 21832234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.